Now accepting Telehealth appointments. Schedule a virtual visit.

Botox


 

Botox is a very well-characterized pure, safe, protein product that when injected into muscle reduces transmission of acetylcholine at the neuromuscular junction. It thereby relaxes the same muscle – for up to months at a time. It’s that simple.

Unfortunately, Botox is often recognized by the general public as a rather frivolous product whose sole use is to remove wrinkles.

Nothing could be further from the truth. Botox has been FDA-approved for over 25 years for many serious conditions including blepharospasm (involuntary spasm of the muscles around the eyes) and torticollis (involuntary spasm of neck muscles), where it has proven revolutionary in improving the lives in those who suffer from these conditions.

In addition, Botox can be used for hyperhidrosis (excessive sweating), hypersalivation (the drooling seen in some Parkinson patients), spasticity, and spastic bladder. The latest FDA-approved use is for chronic migraine headaches (see Neurological Conditions).

Dr. Hutchinson has over 19 years experience with Botox, and routinely injects it for headache, blepharospasm, torticollis, hypersalivation and hyperhidrosis.

At New York Core Neuroscience, we achieve an average 89% reduction in headache frequency using Botox. This result is far superior to the results of the original Allergan study, where there was an average 40% reduction. Moreover, in our hands almost half (44%) of those with daily migraines obtain complete resolution of the headaches. In almost every case where there are residual headaches, these are not only much less frequent, but also much less severe and easy to deal with using simple medications. We attribute our results to the fact that we do not use a standard template of injection sites, but individualize each patient.

Michael Hutchinson, MD, PhD

Dr. Hutchinson is a board-certified neurologist and senior faculty at the Icahn School of Medicine, Mount Sinai, Manhattan. His clinical interests include headaches, dementia, concussion, traumatic brain injury (TBI), Parkinson's Disease, multiple sclerosis, epilepsy, anxiety and REM sleep disorders.  He has an extensive scientific background and brings a science-based approach to solving clinical problems.

During residency at the University of Washington, Hutchinson used his knowledge of chaos theory to propose a new way of treating status epilepticus, the most lethal form of epilepsy. The treatment proved successful and is now standard-of-care in the US. Hutchinson later did a sabbatical at Queen Square, London, where Ian McDonald was pioneering the use of beta interferon as the first treatment for multiple sclerosis.

 

After residency training, Hutchinson underwent a neuroimaging fellowship in Los Angeles.

 

After arriving at NYU in 1994, Hutchinson pioneered the use of cholinesterase inhibitors as a treatment for the dementia of Parkinson's disease. At the time this was considered forbidden because it might make the patient physically worse, but Hutchinson argued that this premise was ill-conceived. Today, cholineserase inhibitors are standard-of-care in Parkinson dementia. Hutchinson later developed a new way of treating acute relapses in multiple sclerosis, which puts the patient in charge, and which has yielded impressive long-term results.

 

During his time at NYU, Hutchinson made early contributions to functional MRI, discovering that regional brain activations during cognitive tasks are accompanied by widespread deactivations.  In structural imaging, Hutchinson combined physics, neuropathology, and image processing to develop a robust MRI biomarker for Parkinson's disease.

 

In addition to certification in neurology, Hutchinson is certified in neuroimaging (MRI and CT of the brain and spine), which combines neuroanatomy, neuropathology and neurophysiology, fields which form the unique base of clinical neurology.

 

Dr. Hutchinson holds a PhD in molecular physics and is inventor of spatial sensitivity encoding for MRI - sometimes referred to as parallel MRI - which is now the acknowledged standard for clinical MRI. He is currently exploring a possible extension of this to ultrafast imaging.

Read more

Michael Hutchinson, MD, PhD

Dr. Hutchinson is a board-certified neurologist and senior faculty at the Icahn School of Medicine, Mount Sinai, Manhattan. His clinical interests include headaches, dementia, concussion, traumatic brain injury (TBI), Parkinson's Disease, multiple sclerosis, epilepsy, anxiety and REM sleep disorders.  He has an extensive scientific background and brings a science-based approach to solving clinical problems.

During residency at the University of Washington, Hutchinson used his knowledge of chaos theory to propose a new way of treating status epilepticus, the most lethal form of epilepsy. The treatment proved successful and is now standard-of-care in the US. Hutchinson later did a sabbatical at Queen Square, London, where Ian McDonald was pioneering the use of beta interferon as the first treatment for multiple sclerosis.

 

After residency training, Hutchinson underwent a neuroimaging fellowship in Los Angeles.

 

After arriving at NYU in 1994, Hutchinson pioneered the use of cholinesterase inhibitors as a treatment for the dementia of Parkinson's disease. At the time this was considered forbidden because it might make the patient physically worse, but Hutchinson argued that this premise was ill-conceived. Today, cholineserase inhibitors are standard-of-care in Parkinson dementia. Hutchinson later developed a new way of treating acute relapses in multiple sclerosis, which puts the patient in charge, and which has yielded impressive long-term results.

 

During his time at NYU, Hutchinson made early contributions to functional MRI, discovering that regional brain activations during cognitive tasks are accompanied by widespread deactivations.  In structural imaging, Hutchinson combined physics, neuropathology, and image processing to develop a robust MRI biomarker for Parkinson's disease.

 

In addition to certification in neurology, Hutchinson is certified in neuroimaging (MRI and CT of the brain and spine), which combines neuroanatomy, neuropathology and neurophysiology, fields which form the unique base of clinical neurology.

 

Dr. Hutchinson holds a PhD in molecular physics and is inventor of spatial sensitivity encoding for MRI - sometimes referred to as parallel MRI - which is now the acknowledged standard for clinical MRI. He is currently exploring a possible extension of this to ultrafast imaging.


Read less
Services

Services

Affiliations

Testimonials

Words from our patients

  • Yelp

    "Finding Dr. Hutchinson has saved my life from migraines that I have suffered from all my life. I love him! I highly recommend him to anyone who needs a neurologist."

    Lisa M.
  • Yelp

    "Dr. Hutchinson is a great physician. He takes time with his patients and really listens to his patients - which is a rarity today in health care!"

    Christine S.
Ask us

Feel free to email us regarding any scheduling or general questions!

Name
Email Address
Comments
Follow Us
Hours

Michael Hutchinson, MD
35 35th St.
Suite 206
New York, NY 10016